Corcept Therapeutics, Inc. (CORT) Posts Narrower than Expected Q2 Loss of 9c/Share
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.